The record
Written by software from the 1 report below. The points restate them; where one says why it matters, that is Prism's reading, not a reported fact.
- The Central Drugs Standard Control Organisation is reviewing a proposal from the Rajasthan government to mandate the public disclosure of pharmaceutical quality test results.
- Currently, drugmakers are required to test products before sale but are not obligated to share these records with the supply chain or the public.
- The initiative follows a recent incident in Kota involving the administration of substandard injections.
- Proponents argue the system will improve transparency, though some industry experts believe focusing on immediate recall mechanisms for substandard products is a more effective safety strategy.
What to watch next
- Potential amendments to the Drugs and Cosmetics Act, 1940 and Rules thereunder, 1945.
- Responses from the Ministry of Health and Family Welfare regarding the implementation of the proposed digital platform.
Who said what2
Only words found exactly in the article are shown, attributed and linked to the line they came from.
Uday Bhaskar
former director general of Pharmexcil
2 quotes · 1 outlet
“Practically, universal digital disclosure is not possible. With manufacturers producing crores of batches and over 8 lakh retail chemists across India, making every record available to all consumers adds no serious value.”
In the article
…quality of drugs is essential and that reports of quality testing conducted by manufacturers at their own level prior to marketing must be made public. Industry experts, however, said the move may not be practical. “ Practically, universal digital disclosure is not possible. With manufacturers producing crores of batches and over 8 lakh retail chemists across India, making every record available to all consumers adds no serious value. Uday Bhaskar, former director general of Pharmexcil, an industry body for the sector's exports. "Instead of these unfeasible plans, authorities should start by focusing on 'not of standard quality' products. Rather…
“Instead of these unfeasible plans, authorities should start by focusing on 'not of standard quality' products. Rather than merely uploading them to a website, that critical information must be communicated immediately down the line to every retailer, wholesaler, and consumer, backed by an effective drug recall mechanism. The priority must be actionable safety over digital platforms”
In the article
…and over 8 lakh retail chemists across India, making every record available to all consumers adds no serious value. Uday Bhaskar, former director general of Pharmexcil, an industry body for the sector's exports. " Instead of these unfeasible plans, authorities should start by focusing on 'not of standard quality' products. Rather than merely uploading them to a website, that critical information must be communicated immediately down the line to every retailer, wholesaler, and consumer, backed by an effective drug recall mechanism. The priority must be actionable safety over digital platforms ,” said Bhaskar. Queries emailed to the spokesperson of health and family welfare ministry, the DCGI office and the Rajasthan drugs controller remained unanswered until press time. Priyanka Sharma is a journalist at…
Coverage1
All filed from India
Named India · Ministry of Health and Family Welfare · Central Drugs Standard Control Organisation · Drugs Controller General of India · Government of Rajasthan · Pharmexcil · Priyanka Sharma · Uday Bhaskar
The 1 report is listed beside the record.
Corrections and versions
A correction says what was wrong and why. Every earlier headline and brief of this record is kept.
Something wrong?
Say what, and it arrives with this record's address filled in. A correction is welcome.
Ask this story
Answers cite the reports above, or say they can't.